The way the announcement made no mention of the adult trial makes me think that the company’s sense is that this might become a full approval which is not conditional on the adult trial commencing, even though it will be happening anyway.. (Remember it won’t cost much because of the BNT-CTN involvement but if successful will vastly expand the market.)
Hope this is the first of many goals being kicked.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-85
-
-
- There are more pages in this discussion • 1,012 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.10 |
Change
-0.030(2.67%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.09 | $3.504M | 3.142M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 125979 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 24813 | 8 |
Last trade - 11.29am 29/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |